Clinical trial: Phase 1, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Evaluate Safety, Tolerability, PK and PD of Antisense Oligonucleotide AMX0114 Administered to Adult Participants With Amyotrophic Lateral Sclerosis

https://clinicaltrials.gov/study/NCT06665165?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_6842

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology